"CphI India 2014": Bormioli Rocco Reinforce their Position in Indian Pharmaceutical Packaging Market
Bormioli Rocco enter the Indian Pharmaceutical Packaging Market. The participation at CphI India in December is just the beginning of this new project.
Italy/ India, December 3, 2014 (Newswire.com) - From 2nd to 4th December 2014 Bormioli Rocco Group will attend the CPHI INDIA exhibition, an international pharmaceutical networking event that will take place in Mumbai. At booth M52 – hall 1, Bormioli Rocco will promote their top products, including a complete range of glass vials type I, II, III, plastic bottles, Child resistant and Tamper Evident plastic closures and accessories.
On this occasion Bormioli Rocco Group will present the new partnership with Brio Pharma Technologies, a well-established Indian company specialized in providing pharmaceutical companies with solutions for processing and packaging for their products.
The partnership is a great opportunity for Bormioli Rocco to strengthen their position in the pharmaceutical packaging sector in India. The main aim is becoming an established player in the local market for glass and plastic packaging leveraging on high reliability, top-quality offer and strong customer oriented service. A continuous pursuit for innovative solutions and technological know-how ensures highest product quality and safety and underpins the leadership position of Bormioli Rocco. Recent strategic investments confirm this and have led to a significant increase of both quality and volume and to an expansion of product portfolio. In addition, the company is certified according to ISO 9001 and ISO 15378, the GMP standards with reference to primary packaging for medicinal products.
Another strong focus of the Bormioli Rocco Group is the consolidation of its leadership in the production of high-quality borosilicate packaging, ideal for all types of injectable drugs and high-end pharmaceutical applications. The company is worldwide well-known for its Type I range of infusion bottles for blood derivative products and vials for parenteral drugs, in a wide range of sizes and shapes. Strict quality controls with 100% of the bottles inspected, ensure highest quality manufacturing. Bormioli Rocco Type I is characterized by high hydrolytic resistance and is manufactured in full compliance with the international Pharmacopeas standards.
Among the offer of borosilicate glass, Bormioli Rocco will also present DELTA, a stand-out range of glass vials for pharmaceutical injectables produced using innovative technology. Delta satisfies the pharmaceutical industry's need for cost savings coupled with superior technical performance compared to existing products in terms of freeze-drying and sterilization.
Moreover, the Bormioli Rocco Group has developed the revolutionary “Anti-Counterfeit” packaging, designed to ensure the highest level of security and integrity of the product, fundamental features especially in the pharmaceutical industry. This system tackles efficiently the phenomenon of counterfeit drugs: a security taggant is incorporated in the packaging. This guarantees full control of the drug along the whole supply chain, patient safety and brand integrity. Moreover, this solution is versatile as it can be incorporated into different types of packaging and offers different levels of customization
Chiara Marando
Press Office Digital Bormioli Rocco Packaging
Zenzero Comunicazione
Via F.S Nitti 14, 43126 Parma
Tel. +390521 969489